ARCA Hero Image
Investor Relations

Press Releases

[+view all]
09.18.2018
ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
08.09.2018
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
07.31.2018
ARCA BIOPHARMA ANNOUNCES POSITIVE OUTCOME OF END-OF-PHASE 2 MEETING WITH FDA ON GENCARO DEVELOPMENT FOR ATRIAL FIBRILLATION
Investor Relations

Press Releases

[+view all]
09.18.2018
ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
08.09.2018
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
07.31.2018
ARCA BIOPHARMA ANNOUNCES POSITIVE OUTCOME OF END-OF-PHASE 2 MEETING WITH FDA ON GENCARO DEVELOPMENT FOR ATRIAL FIBRILLATION
ir-presentations
Presentations
[GO]
ir-reports
Annual Financial Reports
[GO]
ir-filings
SEC Filings
[GO]
ir-faq
Frequently Asked Questions
[GO]
ir-corp-gov

Corporate Governance

Committee Charters

PDF Icon
Audit Committee
PDF Icon
Compensation Committee
PDF Icon
Nominating & Governance Committee

Governance Documents

PDF Icon
Board of Directors Corporate Governance Principles
PDF Icon
ARCA biopharma, Inc. Code of Business Conduct and Ethics
PDF Icon
ARCA biopharma, Inc. Complaint and Investigation Policy and Procedure
PDF Icon
Contact the Board
Chairperson
Member
Chairperson
Member
Audit Committee
Compensation Committee
Nominating & Governance Committee
Raymond L. Woosley, M.D., Ph.D.
Member
Chairperson
Linda Grais, M.D.
Member
Chairperson
Robert E. Conway
Chairperson
Member
Dan Mitchell
Member
Member
Anders Hove, M.D.
Member